Through research at PEPP, patients benefit from new knowledge, resulting in state-of-the-art diagnostic and treatment methods for the early stages of psychosis

Research at the Eating Disorders Program addresses various aspects of the phenomenology, etiology, and treatment of eating disorders in the spectrum of anorexia nervosa and bulimia nervosa.

A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal

Fellowships provide support for senior residents who wish to add to their experience by engaging in mental health research and related activities in the Institute. Candidacy must be approved by the Chair of Psychiatry.

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

Mallar Chakravarty is interested in the anatomy of the brain and how it changes through development, aging, and in illness.

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.